Ginkgo Bioworks Holdings (NYSE:DNA) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ginkgo Bioworks Holdings to report an earnings per share (EPS) of $-1.39.
Ginkgo Bioworks Holdings bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
Last quarter the company missed EPS by $0.21, which was followed by a 20.8% drop in the share price the next day.
Here’s a look at Ginkgo Bioworks Holdings’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.24 | -1.44 | -1.23 | -1.30 |
| EPS Actual | -1.45 | -1.10 | -1.68 | -2.00 |
| Price Change % | -20.80 | -8.69 | 14.73 | -11.47 |
Performance of Ginkgo Bioworks Holdings Shares
Shares of Ginkgo Bioworks Holdings were trading at $8.86 as of February 24. Over the last 52-week period, shares are …